A phase II trial of pemetrexed plus gemcitabine as first-line treatment for locally advanced or metastatic transitional cell carcinoma of the urothelium

被引：0

作者：

von der Maase, H

Lehmann, J

Gravis, G

Joensuu, H

Bihn, B

Geertsen, P

Gough, J

Chen, ZJ

机构：

[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark

[2] Univ Saarland, D-6650 Homburg, Germany

[3] Inst J Paoli I Calmettes, F-13009 Marseille, France

[4] Univ Helsinki, Cent Hosp, Helsinki, Finland

[5] Inst Bergonie, Bordeaux, France

[6] Herlev Univ Hosp, DK-2730 Herlev, Denmark

[7] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：400S / 400S

页数：1

共 50 条

[1] A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
von der Maase, H.
Lehmann, J.
Gravis, G.
Joensuu, H.
Geertsen, P. F.
Gough, J.
Chen, G.
Kania, M.
[J]. ANNALS OF ONCOLOGY, 2006, 17 (10) : 1533 - 1538
[2] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
Xu, Nong
Zhang, Xiao Chen
Xiong, Jian Ping
Fang, Wei Jia
Yu, Lan Fang
Qian, Jiong
Zhang, Ling
[J]. BMC CANCER, 2007, 7 (1)
[3] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
Nong Xu
Xiao Chen Zhang
Jian Ping Xiong
Wei Jia Fang
Lan Fang Yu
Jiong Qian
Ling Zhang
[J]. BMC Cancer, 7
[4] Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial
Dogliotti, Luigi
Carteni, Giacomo
Siena, Salvatore
Bertetto, Oscar
Martoni, Andrea
Bono, Aldo
Amadori, Dino
Onat, Haluk
Marini, Luca
[J]. EUROPEAN UROLOGY, 2007, 52 (01) : 134 - 141
[5] Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Locally Advanced and Metastatic Nonclear Cell Renal Cell Carcinoma
Richey, Stephen L.
Tamboli, Pheroze
Ng, Chaan S.
Lin, E.
Lim, Zita D.
Araujo, John C.
Jonasch, Eric
Sharma, Padmanee
Pagliaro, Lance C.
Tannir, Nizar M.
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 450 - 454
[6] Phase II trial of gemcitabine and cisplatin plus ipilimumab as first-line treatment for metastatic urothelial carcinoma
Gartrell, Benjamin Adam
Hahn, Noah M.
Hutson, Thomas E.
Sonpavde, Guru
Hauke, Ralph J.
Starodub, Alexander
Small, Alexander C.
Tsao, Che-Kai
Galsky, Matt D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[7] Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial
Fogelman, David
Jafari, Mehrdad
Varadhachary, Gauri R.
Xiong, Henry
Bullock, Susie
Ozer, Harold
Lin, E.
Morris, Jeffrey
Cunningham, Patti
Bennett, Bronwyn
Abbruzzese, James L.
Wolff, Robert A.
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1431 - 1438
[8] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
Neri, Bruno
Vannini, Laura
Giordano, Clara
Grifoni, Raffaella
Pantaleo, Pietro
Baldazzi, Valentina
Crisci, Alfonso
Lapini, Alberto
Raugei, Andrea
Carini, Marco
[J]. ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
[9] Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium
Lorusso, V
Crucitta, E
Silvestris, N
Rosati, G
Manzione, L
De Lena, M
[J]. ONCOLOGY REPORTS, 2005, 13 (02) : 283 - 287
[10] Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial
Bajetta, E
Stani, SC
De Candis, D
Bidoli, P
Mariani, L
Zilembo, N
Pozzi, P
Procopio, G
[J]. CANCER, 2000, 89 (04) : 763 - 768

← 1 2 3 4 5 →